💊 Get Accurate, Objective, and Timely Intelligence From DrugPatentWatch
Profile for Jazz Pharmaceuticals plc (JAZZ)
« Back to company indexJAZZ Chatter Timeline
Stock Ticker for JAZZ
Most Active Tweeters for JAZZ
| User | Tweets |
|---|---|
| @TShortalgo | 7 |
| @Gambiste1 | 6 |
| @Beeken_health | 6 |
| @Slayer10Stock | 5 |
| @thudderwicks | 3 |
Recent Tweets for JAZZ
 |
@TShortalgo $JAZZ Trading Ideas | Awaiting Buy signal. 100% Profitability based on 9 trades. Profit factor is 100. Learn more a… https://t.co/rpbAcvvVB2 January 27th 2023, 10:01am |
 |
@newsfilterio Form SC 13G/A (statement of acquisition of beneficial ownership by individuals) filed with the SEC $JAZZ https://t.co/AA2YYtoUxk January 27th 2023, 9:01am |
 |
@Slayer10Stock $JAZZ Put-Call ratio by Volume => 0.24 @ 2023-02-17. Learn more at https://t.co/54bj3mKa5j. #JAZZSTOCK #puts https://t.co/eEbfa0EX7h January 27th 2023, 7:01am |
|
@TShortalgo $JAZZ Trading Ideas | Awaiting Buy signal. 90.91% Profitability based on 11 trades. Profit factor is 5.75. Learn mo… https://t.co/1jSlXSia3T January 26th 2023, 10:01pm |
 |
@TopStockAlerts1 $JAZZ FDA says it will not regulate CBD and calls on Congress to act https://t.co/UcdZCdp3qH January 26th 2023, 7:01pm |
|
@newsfilterio U.S. FDA calls for new regulatory framework for use of cannabis compound CBD $JAZZ https://t.co/oXcQvl9M2U January 26th 2023, 6:01pm |
|
@TShortalgo $JAZZ Trading Ideas | Awaiting Buy signal. 90.91% Profitability based on 11 trades. Profit factor is 5.75. Learn mo… https://t.co/K0pCvvVhOG January 26th 2023, 3:01pm |
|
@Slayer10Stock $JAZZ Put-Call ratio by Volume => 0.24 expiration 2023-02-17. #calls #puts #options ? Chart by… https://t.co/DGzTPxcv8L January 26th 2023, 1:01pm |
|
@Slayer10Stock $JAZZ Put-Call ratio by Volume => 0.24 @ 2023-02-17. Learn more at https://t.co/54bj3mKa5j. #JAZZSTOCK #puts https://t.co/SL5b0h8dxC January 26th 2023, 6:01am |
 |
@SmallTimePotato RT @JD4for4: Niskanen Center files amicus brief in support of narcolepsy patients in $JAZZ v. $AVDL - Niskanen Center — appeal hearing path… January 25th 2023, 10:01pm |
 |
@JD4for4 Niskanen Center files amicus brief in support of narcolepsy patients in $JAZZ v. $AVDL - Niskanen Center — appeal h… https://t.co/BTP21x1SQY January 25th 2023, 10:01pm |
 |
@kjerath RT @bobjohn83869058: $avdl up on big volume and big blocks. Appeal hearing on February 14th should rule in their favor and against $jazz.… January 25th 2023, 8:01pm |
 |
@HScottMatusow GlycoMimetics (GLYC) is a Bigger Deal Than Most Realize https://t.co/4nN6lLHEW4 via @HScottMatusow $GLYC $JAZZ… https://t.co/Ya2Et2fmZt January 25th 2023, 6:01pm |
|
@TShortalgo $JAZZ Trading Ideas | Awaiting Buy signal. 100% Profitability based on 6 trades. Profit factor is 100. Learn more a… https://t.co/W0dlQBljIr January 25th 2023, 5:01pm |
|
@TShortalgo $JAZZ Trading Ideas | Awaiting Buy signal. 100% Profitability based on 6 trades. Profit factor is 100. Learn more a… https://t.co/zF8dHM2jAF January 25th 2023, 9:01am |
 |
@Gambiste1 RT @SnupSnus: @drug_smolecules Or $JAZZ/daiichi all more advanced January 24th 2023, 11:01pm |
 |
@astockwatch1 $JAZZ $ZYME Jazz Pharmaceuticals and Zymeworks Announce 84% Overall Survival at 18 Months from Phase 2 Trial Evalua… https://t.co/GQchxoPO6a January 24th 2023, 7:01pm |
|
@TShortalgo $JAZZ Trading Ideas | Awaiting Short signal. 100% Profitability based on 3 trades. Profit factor is 100. Learn more… https://t.co/f9jHpDjjzT January 24th 2023, 5:01am |
|
@Slayer10Stock $JAZZ Put-Call ratio by Volume => 0.45 @ 2023-02-17. Learn more at https://t.co/54bj3mKa5j. #JAZZSTOCK #stockmarket https://t.co/EFUitVo8ur January 23rd 2023, 4:01pm |
 |
@SnupSnus @drug_smolecules Or $JAZZ/daiichi all more advanced January 23rd 2023, 11:01am |
|
@TShortalgo $JAZZ Trading Ideas | Awaiting Short signal. 100% Profitability based on 3 trades. Profit factor is 100. Learn more… https://t.co/lZGovHwiIc January 23rd 2023, 7:01am |
|
@Slayer10Stock $JAZZ Put-Call ratio by Volume => 0.45 @ 2023-02-17. Learn more at https://t.co/54bj3mKa5j. #JAZZSTOCK #stockmarket https://t.co/coFfm0K5rd January 22nd 2023, 12:01am |
|
@Gambiste1 RT @Beeken_health: $JAZZ - Jazz (JAZZ) Gastric Cancer Study Shows Improved Overall Survival https://t.co/xVQepr65zw January 21st 2023, 7:01pm |
 |
@Beeken_health $JAZZ - Jazz (JAZZ) Gastric Cancer Study Shows Improved Overall Survival https://t.co/xVQepr65zw January 21st 2023, 5:01pm |
|
@Beeken_health $JAZZ - Jazz (JAZZ) Gastric Cancer Study Shows Improved Overall Survival https://t.co/hJQRqX58k9 January 21st 2023, 4:01pm |
|
@Gambiste1 RT @Beeken_health: $JAZZ - Jazz (JAZZ) Gastric Cancer Study Shows Improved Overall Survival https://t.co/7dJtEC865w January 21st 2023, 2:01am |
|
@Gambiste1 RT @Beeken_health: $JAZZ - Jazz (JAZZ) Gastric Cancer Study Shows Improved Overall Survival https://t.co/AXUTGOQxrG January 21st 2023, 2:01am |
|
@Gambiste1 RT @Beeken_health: $JAZZ - Jazz (JAZZ) Gastric Cancer Study Shows Improved Overall Survival https://t.co/zvQNBmjTGI January 21st 2023, 2:01am |
|
@Beeken_health $JAZZ - Jazz (JAZZ) Gastric Cancer Study Shows Improved Overall Survival https://t.co/zvQNBmjTGI January 21st 2023, 1:01am |
|
@Beeken_health $JAZZ - Jazz (JAZZ) Gastric Cancer Study Shows Improved Overall Survival https://t.co/7dJtEC865w January 21st 2023, 1:01am |
|
@Beeken_health $JAZZ - Jazz (JAZZ) Gastric Cancer Study Shows Improved Overall Survival https://t.co/AXUTGOQxrG January 21st 2023, 12:01am |
|
@newsfilterio Form SC 13G (statement of acquisition of beneficial ownership by individuals) filed with the SEC $JAZZ https://t.co/3Lt7mx0t1T January 20th 2023, 11:01pm |
 |
@ChartMill $JAZZ was analyzed by 24 analysts. The buy consensus is at 83%. So analysts seem to be very confident about $JAZZ.… https://t.co/cxBWmhVmUj January 20th 2023, 5:01pm |
 |
@SeekingAlpha $JAZZ - Jazz Pharmaceuticals (JAZZ) Presents At 41st Annual Healthcare Conference - Slideshow.… https://t.co/e0NtqSq4hB January 20th 2023, 12:01pm |
|
@Gambiste1 RT @sunrgu: What are the chances of $JAZZ acquiring $ZYME . Institutional investors buying again but stock going nowhere. January 20th 2023, 2:01am |
 |
@sunrgu What are the chances of $JAZZ acquiring $ZYME . Institutional investors buying again but stock going nowhere. January 20th 2023, 2:01am |
 |
@YaelGruenbaum Go bi specifics ? https://t.co/tDaAhQSZSS and congrats to $JAZZ January 19th 2023, 10:01pm |
 |
@TeamofStockTra $JAZZ - Jazz Pharmaceuticals, Zymeworks Announce Positive Results From Phase 2 Trial of Esophageal Cancer Treatment January 19th 2023, 5:01pm |
 |
@MarcJacksonLA $JAZZ $ZYME Jazz Pharmaceuticals and Zymeworks Announce 84% Overall Survival at 18 Months from Phase 2 Trial Evalua… https://t.co/OUye26v6Z1 January 19th 2023, 3:01pm |
 |
@AlertTrade RT @Briefingcom: $JAZZ: Jazz Pharma and Zymeworks (ZYME) announce tolerability and efficacy results, including the first overall... https:/… January 19th 2023, 2:01pm |
 |
@Briefingcom $JAZZ: Jazz Pharma and Zymeworks (ZYME) announce tolerability and efficacy results, including the first overall... https://t.co/6kApxkT1ey January 19th 2023, 2:01pm |
 |
@raygachette RT @BertrandBio: $Jazz Pharmaceuticals and Zymeworks $ZYME Announce 84% OS at 18 Mo from Phase 2 Trial Evaluating Zanidatamab in HER2+ Meta… January 19th 2023, 2:01pm |
 |
@OpenOutcrier $ZYME (+10.0% pre) Jazz Pharmaceuticals $JAZZ, Zymeworks (ZYME) Announce 84% OS at 18 Months from Phase 2 Trial Eva… https://t.co/Uv8wfA3ajl January 19th 2023, 1:01pm |
 |
@StckPro $JAZZ $ZYME NEW ARTICLE : Zymeworks shares gain on promising data for cancer drug in development with Jazz Pharmace… https://t.co/iSNPCFudWw January 19th 2023, 1:01pm |
|
@Beeken_health $JAZZ $ZYME - Zymeworks shares gain on promising data for cancer drug in development with Jazz Pharmaceuticals https://t.co/D7lWDQRFfv January 19th 2023, 1:01pm |
 |
@BertrandBio $Jazz Pharmaceuticals and Zymeworks $ZYME Announce 84% OS at 18 Mo from Phase 2 Trial Evaluating Zanidatamab in HER… https://t.co/PUWDmkh4KS January 19th 2023, 1:01pm |
 |
@thudderwicks $JAZZ, $ZYME ”The median duration of response was 20.4 months with a median progression-free survival (mPFS) of 12.… https://t.co/v2zmJMMALI January 19th 2023, 12:01pm |
|
@thudderwicks $JAZZ, $ZYME “Treatment with zanidatamab resulted in a confirmed objective response rate (cORR) of 79%, a disease c… https://t.co/he4bQuZWXt January 19th 2023, 12:01pm |
|
@thudderwicks $JAZZ, $ZYME “The preliminary results showed that, at the time of analysis, the median OS had not yet been reached… https://t.co/7HE75moQaF January 19th 2023, 12:01pm |
 |
@FlashAlert_me $JAZZ [15s. delayed]: Issued Press Release on January 19, 07:45:00: Jazz Pharmaceuticals and Zymeworks Announce 84%… https://t.co/7oRebSlFyz January 19th 2023, 12:01pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2023. All rights reserved.